DNAY Insider Trading Activity and SEC Form 4 Filings
DNAY insider trading summary
No open-market insider purchases or sales of Telesis Bio Inc. (DNAY) have been reported on SEC Form 4 in the past 12 months.
Latest DNAY insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 11, 2022 | Todd Robert Nelson | President & CEO | Buy | $192K (122,516 @ $1.56) |
| Jun 22, 2021 | Northpond Ventures, LP | 10% Owner | Buy | $7.5M (468,750 @ $16.00) |
| Jun 22, 2021 | Northpond Ventures GP, LLC | 10% Owner | Buy | $7.5M (468,750 @ $16.00) |
| Jun 22, 2021 | Northpond Ventures II, LP | 10% Owner | Buy | $7.5M (468,750 @ $16.00) |
| Jun 22, 2021 | Michael P. Rubin | 10% Owner | Buy | $7.5M (468,750 @ $16.00) |
| Jun 22, 2021 | Northpond Ventures GP II, LLC | 10% Owner | Buy | $7.5M (468,750 @ $16.00) |
| Jun 18, 2021 | Brent M. Hunter | Sr. Director Corp Controller | Buy | $9K (500 @ $18.25) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.